Lexicon Initiates Phase 3 Clinical Trial of Telotristat Etiprate in Patients

Lexicon Initiates Phase 3 Clinical Trial Of Telotristat Etiprate In Patients

Filed under: drug treatment news stories

Telotristat etiprate is an oral drug candidate designed to treat carcinoid syndrome by reducing serotonin production in patients with metastatic carcinoid tumors. Telotristat etiprate has Fast … Don't insult one another or the subjects of our …
Read more on Sacramento Bee

 

Jasmine Harman: Russell Brand's addiction documentary was amazing

Filed under: drug treatment news stories

This was an enlightening story that gave me a different perspective on drug addicts and alcoholics and the treatment available. It was great to see Russell taking to task a doctor advocating the prescription of methadone for heroin addicts …
Read more on Metro

 

Valeant Pharmaceuticals buys eye drug Visudyne from Vancouver's QLT

Filed under: drug treatment news stories

Visudyne was the drug that made QLT one of Canada's best-known biotech success stories. It is used to treat abnormal growth of leaking blood vessels in the eye caused by wet macular degeneration — a frequent cause of serious blindness for senior …
Read more on Montreal Gazette

 

More drug treatment news stories Resources

Lexicon Initiates Phase 3 Clinical Trial Of Telotristat Etiprate In Patients With Carcinoid Syndrome
THE WOODLANDS, Texas, Oct. 12, 2012 /PRNewswire/ —  Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, … Read News